February 2019 Briefing – Radiology

Here are what the editors at HealthDay consider to be the most important developments in Radiology for February 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.

Advanced Echocardiographic Training Requirements Issued

THURSDAY, Feb. 28, 2019 (HealthDay News) — The training requirements for performing advanced echocardiographic procedures (Level III training) are discussed in a statement from the American College of Cardiology, the American Heart Association, and the American Society of Echocardiography; the report was published online Feb. 19 in the Journal of the American College of Cardiology.

Abstract/Full Text (subscription or payment may be required)

Intervention Can Reduce Racial Differences in Lung Cancer Care

THURSDAY, Feb. 28, 2019 (HealthDay News) — An intervention that includes race-specific feedback and real-time electronic warnings can reduce racial differences in care for early-stage lung cancer, according to a study published online Feb. 4 in Cancer Medicine.

Abstract/Full Text

Performance Improvement Sustained After DBT Adoption

THURSDAY, Feb. 28, 2019 (HealthDay News) — Performance improvements after adoption of digital breast tomosynthesis (DBT) relative to digital mammography (DM) performance have been sustained, regardless of DBT volume, according to a study published online Feb. 26 in Radiology.

Abstract/Full Text (subscription or payment may be required)

MRI Cardiac Stress Test Predicts Death From Heart Disease

TUESDAY, Feb. 26, 2019 (HealthDay News) — Stress cardiac magnetic resonance imaging (CMR) can predict mortality in patients with known or suspected coronary artery disease (CAD), according to a study published online Feb. 8 in JAMA Cardiology.

Abstract/Full Text (subscription or payment may be required)

Stereotactic Radiation Feasible for Oligometastatic Cancer

TUESDAY, Feb. 26, 2019 (HealthDay News) — Stereotactic ablative radiation therapy (SABR) for recurrent oligometastatic cancer is a feasible and tolerable treatment option, according to a phase 2 study published in the January issue of the International Journal of Radiation Oncology, Biology, Physics.

Abstract/Full Text

FDA: Thermography No Substitute for Mammograms

MONDAY, Feb. 25, 2019 (HealthDay News) — Despite claims to the contrary, thermography should not be used in place of mammography for breast cancer screening, detection, or diagnosis, according to the U.S. Food and Drug Administration.

More Information

2014 to 2017 Saw Improvement in Burnout for U.S. Physicians

MONDAY, Feb. 25, 2019 (HealthDay News) — From 2014 to 2017, there was an improvement in burnout and satisfaction with work-life integration among U.S. physicians, according to a study published online Feb. 22 in the Mayo Clinic Proceedings.

Abstract/Full Text

National Health Spending Set to Increase 5.5 Percent Annually